ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

10.50
0.30 (2.94%)
Last Updated: 08:06:50
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.30 2.94% 10.50 10.25 10.75 10.50 10.425 10.43 144,543 08:06:50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -6.44 18.27M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 10.20p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £18.27 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -6.44.

Skinbiotherapeutics Share Discussion Threads

Showing 23501 to 23523 of 23750 messages
Chat Pages: 950  949  948  947  946  945  944  943  942  941  940  939  Older
DateSubjectAuthorDiscuss
02/5/2024
16:22
I assume our partner (Winclover) own our supplement so hold the patents for our skin supplement outside of UK

“29-Apr-2024 Skin care supplement brand Advanced Nutrition Programme (ANP) has attained the ‘UK’s first and only skin microbiome supplement patent’. This next-generation skin supplement, formulated to nurture the close connection between a healthy gut and balanced skin. Stress, diet, antibiotics and some medications are known to cause imbalances in the gut microbiome, which may result in problem skin and imperfections. Skin Clear Biome™ is designed to work from the inside out: feeding the gut with bacteria to clarify and brighten skin.

theterrier
02/5/2024
08:52
Maybe forgot to pay the entry fee
canonlybeone
02/5/2024
08:51
My god., beleno ‘won’ the Golden Beauty Award for microbiome skin products just last year. Maybe they overpaid ?
kreature
02/5/2024
08:35
It is the best conclusion to remove future accounting audits
institutional investments
02/5/2024
08:33
Another one bits the dust. seemed to have experienced corp team, encouraging sales, deals and clinical products in a number of our areas. One less competitor, i guess. The lack of corp sector knowledge/poor management we have will I am sure take us the the same conclusion in my view. We can only hope something is left when they have finished.

The company BELANO medical AG announces that the business operations, along with all intangible and tangible assets, have been closed with the consent of the insolvency administrator, Dr. Sven Kirchner and with the approval of the creditors' meeting was sold to Rigix GmbH. The proceeds from the sale will go to the company's insolvency estate. BELANO medical AG is being wound up as part of the insolvency proceedings. All employment relationships were terminated or terminated.

theterrier
29/4/2024
09:45
morning gerbys

glorious PING today

thanatos abysss
29/4/2024
09:32
Actually that would be very prudent. Excellent suggestion
institutional investments
29/4/2024
09:27
Maybe prudent to wait to see if there are no more mugs in the pipeline before lowering the share price ? Perhaps he has another 75k to shift
kreature
29/4/2024
09:10
just looking at the dumping elsewhere off L2, like 75000 at 1627 on Friday, and ask myself, how has the maker this priced at 9p today?
institutional investments
28/4/2024
11:35
If not sure how to, SYME has a great 10 year course on offer, via financials and podcasts
thanatos abysss
28/4/2024
10:47
If not sure how to, OPTI has a great 10 year course on offer, via financials and podcasts
institutional investments
28/4/2024
10:45
Expect normal operational losses to be maintained or increase next time around

Probably best to get the next one 'out of the way' and focus on the one after, with great imagination and podcasts

institutional investments
28/4/2024
10:42
Probably means costs will match plus extra cash extraction acquisitions and other methodologies to be added to de-risk?
institutional investments
Chat Pages: 950  949  948  947  946  945  944  943  942  941  940  939  Older

Your Recent History

Delayed Upgrade Clock